Company: MYGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000899923-25-000019
Chunk: 183

Company: MYRIAD GENETICS INC
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 183
---
 orScheduleFiling DateSEC File/RegistrationNumber10.17Chief Operating Officer Severance and Change of Control Agreement, dated December 11, 2023, by and between Myriad Genetics, Inc. and Samraat S. Raha+10-K (Exhibit 10.16)2/28/2024000-2664210.18Executive Employment Agreement, dated December 15, 2023, between Myriad Genetics, Inc. and Scott Leffler+10-K (Exhibit 10.17)2/28/2024000-2664210.19Amended and Restated Employment Agreement, dated February 24, 2025, between Myriad Genetics, Inc. and Samraat S. Raha+8-K(Exhibit 10.1)2/24/2025000-2664210.20Chief Executive Officer Severance and Change of Control Agreement, dated February 24, 2025, by and between Myriad Genetics, Inc. and Samraat S. Raha+8-K(Exhibit 10.2)2/24/2025000-2664210.21Employment Agreement, dated February 24, 2025, by and between the Company and Mark S. Verratti+ 8-K(Exhibit 10.3)2/24/2025000-2664210.22Severance and Change of Control Agreement, dated February 24, 2025, by and between the Company and Mark S. Verratti+8-K(Exhibit 10.4)2/24/2025000-2664210.23Consulting Agreement, dated February 24, 2025, by and between the Company and Paul J. Diaz8-K(Exhibit 10.5)2/24/2025000-26642Equity Compensation Plans10.242017 Employee, Director and Consultant Equity Incentive Plan, as amended (June 1, 2023)+8-K(Exhibit 10.1)6/2/2023000-2664210.25Form of Restricted Stock Unit Agreement under the 2017 Equity Incentive Plan+10-K(Exhibit 10.11)8/13/2020000-2664210.26Amended and Restated 2012 Employee Stock Purchase Plan+ 8-K(Exhibit 10.1)6/2/2022000-